Related by context. Frequent words. (Click for all words.) 60 Morgan Stanely 60 analyst Mark Schoenebaum 57 Joel Sendek 57 Analysts Downgrade 57 Andrew Kligerman 56 Jason Gurda 55 analyst William Pecoriello 55 Eyetech Pharmaceuticals 55 Reiterates Buy Rating 55 analyst Jami Rubin 55 analyst Maynard Um 54 please visit www.ml.com 54 analyst Pablo Zuanic 54 BoA Merrill Lynch 54 Hussein Allidina 54 Neutral Weight 53 Broker Roundup 53 analyst Stephen Tusa 53 Bret Holley 53 marketperform 53 ThinkEquity Partners LLC 53 analyst Charles Boorady 53 Piper Jaffray PJC 53 Maintains Hold 53 J.P. Morgan 53 Leerink 52 Ben Reitzes 52 Maintains Buy 52 RESEARCH ALERT 52 Chief Equity Strategist 52 Brent Thill 52 FBR Capital Maintains 52 Punk Ziegel 52 Tanona 52 Michael Vinciquerra 51 Valeant Pharma 51 Lexicon Pharmaceuticals 51 marketweight 51 JP Morgan 51 Morgan Stanley 51 UBS Warburg LLC 51 Barclays Maintains 51 Reiterates Buy 51 Raises PT 51 Ariad Pharmaceuticals 51 BofA ML 51 Auriga USA 51 analyst Glyn Lawcock 51 RDQ Economics wrote 51 Equal Weight rating 51 Geoffrey Porges 51 analyst Glenn Schorr 51 Sagent Advisors 50 LODH 50 Sipkin 50 Adrianne Shapira 50 Kaufman Bros 50 analyst Nikos Theodosopoulos 50 Kevin Buchi 50 analyst Connie Maneaty 50 Cyclacel Pharmaceuticals 50 Rigel Pharmaceuticals 50 Edward Najarian 50 MS NASDAQ MNDX 50 Bristol Myers BMY 50 UBS 50 Drew Matus 50 analyst Benjamin Reitzes 50 Ardour Capital 50 Jon LeCroy 50 Joshua Shanker 50 Jay Gelb 50 Gilead Sciences NASDAQ GILD 50 Axcan Pharma 50 analyst Sasa Zorovic 50 analyst Guy Moszkowski 50 analyst Douglas Sipkin 50 Joseph Osha 50 FBR Capital Reiterates 49 Andrew Garthwaite 49 Helvea 49 NASDAQ SLXP 49 NYSE PJC 49 Eric Coldwell 49 HealthCor 49 Underweight rating 49 ACADIA Pharmaceuticals 49 analyst Heather Bellini 49 Raises Estimates 49 Sunesis Pharmaceuticals 49 Daniel Berenbaum 49 Ladenburg Thalmann analyst 49 Glenn Schorr 49 RBC Capital NYSE RY 49 Simeonidis 49 Brigantine Advisors 49 analyst Joseph Greff 49 Emkay Global 49 Mindray Medical 49 Tobias Levkovich 49 ZIOPHARM Oncology